Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds
MIAMI, Jan. 05, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company […]
Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders
Shareholders of Record Received Warrants to Purchase Shares of Common Stock Warrants Trade on Nasdaq Under the Ticker “SAVAW” Warrant […]
SB Financial Group, Inc. Announces Schedule for Fourth Quarter and Full Year 2023 Results
DEFIANCE, Ohio, Jan. 05, 2024 (GLOBE NEWSWIRE) — SB Financial Group, Inc. (NASDAQ: SBFG), a diversified financial services company providing […]
Castor Maritime Inc. Announces the Sale of the M/V Magic Venus for $17.5 Million with an Expected Net Gain of $3.5 Million
LIMASSOL, Cyprus, Jan. 05, 2024 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM), (“Castor” or the “Company”), a diversified global […]
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies
SEATTLE, Jan. 05, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for […]
Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination
The pro forma equity value of the portion of the combined company attributable to Tevogen Bio Inc (“Tevogen Bio”) stockholders […]
Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose […]
Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones
– EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively – […]
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
If approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema […]
Banzai Executes LOI to Acquire Top Rated Lead Generation Platform, IGLeads
SEATTLE, Jan. 05, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology […]
